Malaria Therapy
Novel FR900098 prodrugs show improved antimalarial activity
Published in TB and Outbreaks Week, August 12th, 2003
"FR900098 represents an improved derivative of the new antimalarial drug fosmidomycin and acts through inhibition of the 1-deoxy-D-xylulose 5-phosphate (DOXP) reductoisomerase, an essential enzyme of the mevalonate independent pathway of isoprenoid biosynthesis," scientists in Germany explained.
In a study conducted by R. Ortmann and colleagues at the University of Munich, FR900098 prodrugs "with increased activity after oral administration were obtained by chemical modification of the phosphonate moiety to yield acyloxyalkyl esters."
"The most successful...
Want to see the full article?
We're a pay-per-view site for premium content. If you'd like to purchase this article, it's only $3.00.
Welcome to NewsRx!
Learn more about a six-week, no-risk free trial of TB and Outbreaks Week
More Articles from TB and Outbreaks Week
- Tuberculosis Diagnosis
Novel PBMC-based tuberculosis immunoassay fast, accurate - Tuberculosis Pathogenesis
Interleukin-8 gene mutations affect tuberculosis susceptibility - Blood Safety
High HTLV-1 rate confirmed in blood donors from Iranian city - Infectious Disease Therapy
Novel acylides active against Gram-positive and -negative pathogens - Legionnaires Disease
Monoclonal antibody typing useful for identifying genotypic subgroups - Pulmonary Tuberculosis Diagnosis
Interferon gamma levels in whole blood can help determine tuberculosis severity - More from this issue of TB and Outbreaks Week
NewsRx is Social
Follow us on your favorite social network by clicking on a button below:
Top Medical Newsletters
Awards
Best Health/Healthcare Content, 2012
Best Health/Healthcare Content, 2011
Best e-Business Site, 2010
Best e-Business Site, 2009
Best e-Business Site, 2008
Best e-Business Site, 2007
Best e-Business Site, 2006
Best Healthcare Content, 2005
Best Overall Internet Site, 2005
Best Interactive Site, 2005
Facts & Stats
NewsRx also is available at LexisNexis, Gale, ProQuest, Factiva, Dialog, Thomson Reuters, NewsEdge, and Dow Jones.
- Google 2010 PageRank: #2 Among Top Health News and Media Publications
- Google 2010 PageRank: #2 Among Top Science Publications in Biology/Physiology
- Google 2010 PageRank: #2 Among Top News and Media for the Business of Pharmaceuticals
- Amazon's Alexa 2010 PageRank: #2 News and Media Site for the Pharmaceutical Industry
